Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a ...

An international team of researchers has developed the largest genomic data set in the world on Lassa virus (LASV). The new genomic catalog contains nearly 200 viral genomes collected from patient ...

GAITHERSBURG, Md., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (EBS) today announced that it has dosed the first participant in its Phase 1 study evaluating the safety and ...

LAWRENCEVILLE, N.J., Aug. 24, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, announces it has entered into a Cooperative Research and Development ...

Centers for Disease Control and Prevention-led research demonstrates that an oral antiviral drug, 4′-fluorouridine (4′-FlU), effectively inhibits lethal arenavirus infections in animal models.

The clinical trial of a Lassa fever candidate vaccine has begun enrolling participants at the University of Maryland School of Medicine, Baltimore. Lassa virus (a member of the Arenavirus family) ...

By Olakunle OlafioyeGrim statistics and rising numbers of deaths from Lassa fever infection have once again put Nigeria in the spotlight for a wrong reason. No fewer than 20 local government areas in ...

The Lassa fever vaccine candidate — a replication-competent recombinant vesicular stomatitis virus-vectored vaccine encoding a Lassa virus (LASV) glycoprotein complex (rVSVΔG-LASV-GPC) — demonstrated ...

African health authorities on Thursday confirmed a possible outbreak of an unidentified viral hemorrhagic fever in southern Ethiopia that is under investigation after eight suspected cases were ...

Baamlong said the patients were currently being treated and the ministry has commenced an active contact tracing and surveillance in line with the national and international public health protocols.